Dear AACE Community,

As 2025 comes to a close, I am honored to reflect on our accomplishments during an amazing year and on the successful completion of the 2022–2025 Strategic Plan. Our progress across education, advocacy, member engagement, and global collaboration speaks to the collective strength, commitment, and passion of our community. It has been a privilege to serve as President during such a pivotal and transformative period for AACE. While it is impossible to fully capture all that we have achieved together, I am proud to highlight several key milestones, organized within the three strategic goals that have guided our work since 2022.

Goal 1: Endocrine Care Team Leadership

AACE empowers and supports endocrinologists as leaders in optimal clinical care.

Our commitment to supporting endocrinologists as the leaders of the endocrine care team shaped every major initiative this year. The following achievements show how we advanced this goal together.

One of the most meaningful aspects of this year’s meeting was reconnecting with our former AACE Chapters. Advocacy provides an important pathway for AACE to remain closely connected with regional organizations as we work together to address issues impacting endocrine care. We made progress on several key AACE Advocacy priorities this year including expanding access to obesity medications, supporting CGM quality measures, and advocating for Medicare coverage and reimbursement reforms for essential endocrine services. We also launched a four-part AACE Advocacy Webinar Series, now available on-demand throughout 2026.

Certificate Programs

In 2025, we launched five new AACE Certificates, bringing our total to seven comprehensive educational programs for the entire endocrine care team. These include:

• Fundamentals of Diabetes Technology
• Fundamentals of Obesity and Weight Loss
• Inpatient Diabetes
• Hands-On Diabetes Technologies and Skills Certificate
• Hands-On Thyroid Nodules Certificate
• Dyslipidemia and Lipids Management
• Osteoporosis and Bone Health

We also expanded courses in osteoporosis, obesity, diabetes, MASLD and MASH, rare endocrine diseases, and additional endocrine conditions. These programs offer high-quality, evidence-based education for all members of the endocrine care team.

Endocrine University

Endocrine University continued to set the standard for early-career endocrinology training. In 2025, we welcomed more than 290 Year 1 fellows and more than 300 Year 2 fellows. This is an all-time attendance record for the EU program. Through live sessions and a comprehensive curriculum, fellows-in-training strengthened their clinical skills, particularly in new technology, which has become essential to the practice of endocrinology. As we look to the future, AACE remains committed to equipping the next generation of endocrinologists with the knowledge and skills needed to deliver high-quality, patient-centered care.

Topical Interest Groups

To better connect our rapidly growing global community, we launched new Topical Interest Groups on Facebook, including the Artificial Intelligence and Clinical Endocrinology Community and the Environmental Endocrinology Community. These forums foster collaboration and exchange of insights. Next year we will expand these groups to include a Private Practice Community, offering members additional opportunities to connect, share real time perspectives, and discuss emerging trends shaping endocrine care.

Clinical Guidance Documents

AACE is committed to equipping endocrinologists and the entire endocrine care team with the tools and knowledge needed to deliver evidence-based care. I’m proud to share this year we published four new clinical guidance documents:

• Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia
• Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1
• AACE Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update
• AACE Consensus Statement: Algorithm for the Evaluation and Treatment of Adults With Obesity/Adiposity-Based Chronic Disease – 2025 Update

We also hosted our inaugural AACE Clinical Guidance Forum on December 10 and 11, a virtual CME program that allowed members to learn directly from the authors of our 2025 clinical guidance documents. Attendees explored evidence-based recommendations in obesity, dyslipidemia, MEN type 1, and menopause management, and gained practical insights for integrating these updates into everyday practice. All content is now available on demand throughout 2026.

Goal 2: Patient Awareness and Engagement

AACE is the trusted source for endocrine disease and care delivery information.

In 2025, we expanded our Patient Journeys and Patient Guides to provide clinically accurate, easy-to-navigate, patient-centered resources. These tools help individuals understand their endocrine conditions from diagnosis to long-term management and empower patients to play an active role in their care.

Our Patient Journeys advanced significantly this year across thyroid disease, obesity, and diabetes technology. Following the publication of our 2025 AACE Obesity Algorithm, we updated our Journey for Patients With Obesity to reflect the latest treatment recommendations and added new content to support patient self-advocacy. We also began translating our Patient Journeys into Spanish to better meet the needs of our global community.

We have also developed a patient summary of our Clinical Practice Guideline for the Pharmacologic Management of Persons With Dyslipidemia and a MASLD and MASH Patient Guide, which quickly became one of the most accessed resources in our library.

These achievements would not have been possible without the volunteer work of our medical content advisors, the engagement of our patient partner groups, and the support of our industry sponsors. We will continue to expand our patient resource library to serve as the trusted source for endocrine disease information and to raise awareness among patients and the public.

AACE’s media presence also grew significantly this year, with interviews conducted across several major outlets. Below are some media highlights, with a complete list of recent press citations available at AACE in the News.

• The Wall Street Journal - The Promise and Hurdles of the New Weight-Loss Pills
• The Wall Street Journal - My Digestive Tract Flunked a Health Test. Here’s How I’m Coping
• The Wall Street Journal - Should Everyone Be Taking Ozempic?
• NPR - Patients turn to 'gray market' for cheaper obesity drugs, but it's risky
• NPR - Online sales of obesity drug alternatives carry on despite FDA deadlines
• NPR - Consultations for obesity drug prescriptions are way up over 2023, survey finds
• Firstpost PoV (National News in India) - Weight Loss Drugs: Should You Take Them or Not?
• The Curbsiders Internal Medicine Podcast - Prediabetes and Diabetes Prevention

As we conclude our 2022-2025 Strategic Plan, we do so with a deep sense of accomplishment and gratitude. Many of the programs and resources I’ve highlighted above are made possible through the support from our Industry Partners and specifically our Corporate AACE Partnership (CAP), a group of industry organizations that share our commitment to advancing endocrine care. Their collaboration enables us to develop new educational offerings, strengthen our clinical resources, and provide opportunities for clinicians to stay current with the latest advancements in the field. I am grateful to our CAP members for their partnership and dedication to our mission.

Looking Ahead: Our 2026–2029 Strategic Plan

The 2026 to 2029 Strategic Plan will build on our strong foundation, with new goals focused on:

• Goal 1: Be the Professional Home for Clinical Endocrinologists & the Endocrine Care Team
• Goal 2: Define, Advocate, & Influence Quality Endocrine Care for All
• Goal 3: Engage the Global Endocrine Community to Advance Knowledge & Patient Health

These goals will guide us as we create new pathways for learning, strengthen AACE’s support for the endocrinologist as the leader of the endocrine care team, and develop programs that reflect the evolving needs of our members, patients, and global community. Our President Elect, Dr. Dace Trence, will share more in the new year about how our 2026 to 2029 Strategic Plan will shape the next chapter of AACE. Her leadership and vision will help us continue to innovate, collaborate, and lead the way in advancing clinical endocrinology care worldwide.